Navigation Links
Bio-AMD, Inc.; DSR Commercial Refinement, Prospective Patent Applications
Date:12/21/2011

prospect of entering into commercial development and licencing agreements(s) for DSR in 2012. Manufacturers and distributors not yet in discussion with Bio-AMD Limited may contact the company at www.bioamd.com.

About Bio-AMD, Inc.

Bio-AMD has two majority owned UK subsidiaries: Bio-AMD Limited, a technology developer for medical diagnostic devices; and the WDX Organisation Ltd, the owner of the Wocu™, a global currency data reference source for application in financial markets. (www.wocu.com).

To find out more about Bio-AMD (OTCBB: BIAD), visit our websites at www.bioamd.com.

Forward-Looking Statements

Statements in this news release that are not statements of historical fact are forward-looking statements, which are subject to certain risks and uncertainties.  Forward-looking statements can often be identified by words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import.  Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management.  Actual results may differ materially from those expressed or implied by forward-looking statements due to a variety of factors that may or may not be foreseeable or within the reasonable control of the Company.  Readers are cautioned not to place undue reliance on such forward-looking statements.  Additional information on risks and other factors that may affect the business and financial results of the Company can be found in filings of the Company with the U.S. Securities and Exchange Commission, including without limitation under the caption "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December
'/>"/>

SOURCE Bio-AMD, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Vista Partners Updates Coverage on Opexa Therapeutics, Inc.; Raises Target Price From $4.40 to $6.50
2. ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells
3. VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent
4. Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
5. Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
6. CMS, Inc., an Elekta Company, Announces Commercial Availability of Focal4D(TM)
7. Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program
8. NicOx Signs Agreement With Capsugel for the Commercial Manufacture of Naproxcinod Oral Capsules
9. Samaritan Partners Forgetful Rat Model to Taconic to Commercialize
10. POET Receives Additional $76 Million in Federal Funding For Commercialization of Cellulosic Ethanol
11. Oncolytics Biotech Inc. Completes Initial Scale Up of Manufacturing Process for REOLYSIN(R) to Commercial Scale
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013 Biotechnology industry pioneer Amgen ... software provider BlackLine Systems  and enterprise application software ... for a webinar next week entitled "No Account Left ... and SAP to Help Keep Its Account Reconciliations in Good ... The webinar, geared at finance, accounting, audit ...
(Date:6/19/2013)... June 19, 2013 India’s vast ... can potentially be worth up to a billion ... the Indian government is taking serious action to ... process. , This presentation will examine:, ... ,     Immediate and long term impacts , ...
(Date:6/19/2013)... Earth, MN (PRWEB) June 19, 2013 ... of abuse tests, today announced that it has received ... to market and sell its DrugCheck® NxStep Onsite ... allows use of the rapid screening device in near-patient ... Onsite Drug Screen Cup received Health Canada Class III ...
(Date:6/18/2013)... A million electric cars could be on roads across ... help of research by the United States Department of Energy, ... Professor Zhongwei Chen is part of a team led by ... to replace the expensive platinum catalysts in fuel cells. , ... cells in vehicles is the cost of the units. The ...
Breaking Biology Technology:Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3US and Canadian researchers drive towards cheaper fuel cells for electric cars 2
... The firm's shares shot up 40% this morning after it ... drug in the company's pipeline, has been found to extend ... ,Late last week, new data and a regulatory decision buttressed ... - news - people ) is developing ...
... (WMC), Valhalla, New York, has selected Verisis developed by ... Corporation , for its new Cardiology Image and Information Management ... George E. Reed Heart Center , one of the ... east coast. The system will also extend into the ...
... of streaming media was predominantly targeted toward consumer applications ... money hasn't followed. The focus on streaming media is ... that can improve productivity and the information experience. Just ... educational institutions are beginning to see the value of ...
Cached Biology Technology:Genentech's Winning Streak 2Genentech's Winning Streak 3NY Medical Center Selects Camtronics for Cardiovascular Image and Information Management 2
(Date:6/19/2013)... of the patients who received injections of steroids ... New England Compounding Center has found that some ... not experience a worsening of their symptoms and ... infection, especially among those individuals who received injections ... along with an editorial by UC Davis Assistant ...
(Date:6/19/2013)... 2013 A study published in the Journal ... report of an oral probiotic supplement significantly increasing circulating ... The lead author on the study, Mitchell Jones, MD, ... from the New York Academy of Sciences and the ... Prebiotics, and the Host Microbiome: The Science of ...
(Date:6/19/2013)... Flemish plant scientist Marc Van Montagu (born 1933) is ... the American scientists Mary-Dell Chilton and Robert T. Fraley. ... the US Secretary of State, John Kerry. The World ... agriculture" - gives the award annually to one or ... importance for the quality, quantity or availability of food. ...
Breaking Biology News(10 mins):Evolution of an outbreak: Complications from contaminated steroid injections 2Study shows probiotic Lactobacillus reuteri NCIMB 30242 significantly increased vitamin D levels 2World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 2World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 3World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 4
... A specific biological response to cellular stress may predict ... common, non-invasive form of pre-malignant breast cancer-- ductal carcinoma ... could potentially be used in a clinical setting to ... therapy when initially diagnosed with DCIS, according to a ...
... Using an extremely sensitive measurement technique, researchers at ... a lead-specific DNAzyme uses the lock and key reaction ... the same DNAzyme uses the induced fit reaction ... and key mechanism explains why this particular lead-specific DNAzyme ...
... a new vaccine be the key to stopping Alzheimers ... Research Foundation (OMRF) shows that immunization could offer a ... disease. OMRF scientists immunized Alzheimers mice with a ... disease-causing process. The mice who received the vaccination showed ...
Cached Biology News:Cell response to stress signals predicts tumors in women with common pre-breast cancer 2Cell response to stress signals predicts tumors in women with common pre-breast cancer 3The key to unlocking the secret of highly specific DNAzyme catalysis 2An Alzheimer's vaccine? 2An Alzheimer's vaccine? 3
Comp Dim: chamber diam. depth 20 2.8 mm chamber maximum volume 720 μL...
...
... A direct, simple approach ... the well surface of an ... anhydride maintains its integrity and ... under dry, room temperature conditions ...
... adsorption and clarification reagent; Ideal for ... of antibodies, proteins, nucleic acids, & ... cross-reactivity, and improves downstream processing; Utilizes ... non-ionic adsorbent supplied as a suspension ...
Biology Products: